CD8A and neoplasm: Using the scTCR-seq and scRNA-seq data from 4 patients with matched tumor and adjacent normal samples, we found 23.9% of the T-cell clones in tumors were shared with normal samples, suggesting the parallel expansion of TEFF and TMEM-CD8 in these sites (Supplementary Data 7)42.